NDC 0548-5001
Ganirelix Acetate
Ganirelix Acetate
Ganirelix Acetate is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Amphastar Pharmaceuticals, Inc.. The primary component is Ganirelix Acetate.
| Product ID | 0548-5001_0e71b74d-723d-46a4-b2e5-7c7157949ad4 |
| NDC | 0548-5001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ganirelix Acetate |
| Generic Name | Ganirelix Acetate |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-06-20 |
| Marketing Category | ANDA / |
| Application Number | ANDA212613 |
| Labeler Name | Amphastar Pharmaceuticals, Inc. |
| Substance Name | GANIRELIX ACETATE |
| Active Ingredient Strength | 250 ug/.5mL |
| Pharm Classes | Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |